Results 241 to 250 of about 111,950 (304)
This study found that aging‐related cognitive impairment is accompanied by hippocampal microglial senescence. Ghrelin suppresses microglial senescence by promoting autophagy through the SHBG/JNK1/Beclin1 axis, thereby alleviating aging‐related cognitive impairment. The graphical abstract was drawn using the Figdraw.
Lixing Zhou +9 more
wiley +1 more source
Double heterozygous germline pathogenic variants in patients referred to a tertiary cancer genetics clinic in Singapore. [PDF]
Wong RSJ +6 more
europepmc +1 more source
The ‘Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease’ (PATROL) study
Background Inherited (germline) pathogenic and likely pathogenic variants (gPVs) in key genes associated with increased risk of prostate cancer (PCa) now warrant more attentive PCa screening per National Comprehensive Cancer Network (NCCN) guidelines—e.g., BRCA2, HOXB13, ATM, BRCA1, MSH2, MSH6, CHEK2 and TP53.
Heather H. Cheng +12 more
wiley +1 more source
Differential roles of BRCA1 and BRCA2 in the DNA damage response revealed by isogenic V79 mutant cell lines. [PDF]
Chailapakul P +3 more
europepmc +1 more source
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications. [PDF]
Banda K +14 more
europepmc +1 more source
Copy number variation analysis in The Cancer Genome Atlas identified NTAQ1 as a potential driver of HCC progression. NTAQ1 accelerates tumor growth by promoting the degradation of the tumor suppressor protein PRDM2, thereby impairing DNA repair and suppressing apoptosis. These findings indicate that NTAQ1 could be a valuable target for the treatment of
Tomohiko Ikehara +21 more
wiley +1 more source
The Landscape of BRCA1-Associated Post-Translational Modifications. [PDF]
Waduge NH, Xiao J, Davis GM.
europepmc +1 more source
Multi‐region sequencing of 57 BRCA1‐associated breast cancers identified TP53 as the dominant initial driver, defining a triple‐negative subgroup with biallelic BRCA1 loss and elevated genomic instability. TP53 truncating mutations were enriched in BRCA1 carriers and linked to reduced HRD, EMT activation, and a trend toward worse survival.
Li Hu +13 more
wiley +1 more source
Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study. [PDF]
Kelemen I +17 more
europepmc +1 more source
Reproductive Challenges in Mutated BRCA Gene Carriers: A Narrative Review. [PDF]
Vouza M +5 more
europepmc +1 more source

